Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Acquisitions (2017)

Soleno Therapeutics (SLNO) has disclosed Acquisitions for 1 consecutive years, with -$408.0 as the latest value for Q4 2017.

  • Quarterly Acquisitions changed N/A to -$408.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $349592.0 through Dec 2017, changed N/A year-over-year, with the annual reading at $572592.0 for FY2017, N/A changed from the prior year.
  • Acquisitions for Q4 2017 was -$408.0 at Soleno Therapeutics, down from $350000.0 in the prior quarter.
  • The five-year high for Acquisitions was $350000.0 in Q3 2017, with the low at -$408.0 in Q4 2017.